12:12 PM EDT, 08/13/2025 (MT Newswires) -- ReShape Lifesciences' ( RSLS ) merger with Vyome Therapeutics received approval from Nasdaq for listing upon completion of the deal, expected to take place at the market open on Aug. 15, Vyome announced Wednesday.

The merged company will trade under the ticker "HIND."

ReShape's board also declared a 1-for-4 reverse stock split of its common shares, effective Aug. 15, according to the statement.

ReShape shares were up past 35% in recent trading.

Price: 2.35, Change: +0.32, Percent Change: +15.81